Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 975-985

  Kim, Kwangpyo ^a   Jung, Sung Yun ^b   Lee, Duk Keun ^a   Jung, Jae Kyung ^a   Park, Jong Koo ^a   Kim, Dae Kyong ^b   Lee, Chul Hoon ^a  

^a CJ Corporation   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Arachidonic acid; Inflammation; Inhibitor; Phospholipase A2; Surfactin

Indexed keywords

ACETYLSALICYLIC ACID; CALCIMYCIN; INDOMETACIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE INHIBITOR; SURFACTIN;

ANALGESIA; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL LINE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIALYSIS; DOSE RESPONSE; ENZYME BINDING; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; IN VITRO STUDY; KIDNEY CELL; MALE; MONKEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OTITIS; PAW EDEMA; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; TOPICAL DRUG ADMINISTRATION;

ACETIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; BACTERIAL PROTEINS; BLOOD PLATELETS; BLOTTING, WESTERN; CALCIMYCIN; CYTOSOL; EDEMA; ENZYME INHIBITORS; HAPLORHINI; INFLAMMATION; ISOENZYMES; KIDNEY; MALE; MICE; PAIN; PEPTIDES, CYCLIC; PHOSPHOLIPASES A; RATS;

EID: 0032055265     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00613-8     Document Type: Article

References (37)

1. Van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta. 604:1980;191-246.
2. Hanahan D.J. Platelet activating factor A biologically active phosphoglyceride . Annu Rev Biochem. 55:1986;483-509.
3. 2 in the pathobiology of disease. Lab Invest. 55:1986;391-404.
4. 2 and signal transduction. J Am Soc Nephrol. 3:1992;128-150.
5. 2. Biochim Biophys Acta. 1170:1993;217-231.
6. 2. J Biol Chem. 269:1994;13057-13060.
7. 2 activity which preferentially hydrolyzes an arachidonoyl residue. J Biochem (Tokyo). 104:1988;492-494.
8. 2 in rat renal mesangial cells. J Biol Chem. 263:1988;16645-16651.
9. 2. Biochim Biophys Acta. 1083:1991;80-88.
10. 2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem. 266:1991;5268-5272.
11. 2 from bovine platelets. Biochem Biophys Res Commun. 174:1991;189-196.
12. 2 from rat kidney activated at physiological calcium concentrations. Biochem J. 271:1990;37-43.
13. 2 from the human monocytic cell line U937. Proc Natl Acad Sci USA. 87:1990;7708-7712.
14. 2. Br J Pharmacol. 110:1993;447-453.
15. 2 by quercetin. Inflammation. 17:1993;573-582.
16. 2-specific inhibitor from ascomycetes. J Antibiotics (Tokyo). 47:1994;631-638.
17. 2. Biochemistry. 32:1993;5935-5940.
18. Arima K., Kakinuma A., Tamura G. Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis Isolation, characterization and its inhibition of fibrin clot formation . Biochem Biophys Res Commun. 31:1968;488-494.
19. Kakinuma A., Tamura G., Arima K. Wetting of fibrin plate and apparent promotion of fibrinolysis by surfactin, a new bacterial peptidelipid surfactant. Experientia. 24:1968;1120-1121.
20. Nakano M.M., Zuber P. Molecular biology of antibiotic production in Bacillus. Crit Rev Biotechnol. 10:1990;223-240.
21. 2 inhibitor isolated from Bacillus subtilis. Korean Biochem J. 26:1993;625-631.
22. 2 activity . Biochem J. 294:1993;261-270.
23. 2 activity in human brain. J Neurochem. 64:1995;2213-2221.
24. 2 activities are increased in human adult respiratory distress syndrome. Am J Physiol. 269:1995;L109-L118.
25. Young J.M., Wagner B.M., Spires D.A. Tachyphylaxis in 12-O-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema. J Invest Dermatol. 80:1983;48-52.
26. Young J.M., Spires D.A., Bedord C.J., Wagner B., Ballaron S.J., De Young L.M. The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol. 82:1984;367-371.
27. 2. FEBS Lett. 268:1990;113-116.
28. Deraedt R., Jouquey S., Delevallée F., Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol. 61:1980;17-24.
29. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65:1991;1043-1051.
30. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem. 269:1994;15619-15624.
31. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem. 269:1994;15625-15630.
32. 2. J Biol Chem. 266:1991;7227-7232.
33. Baek D-J, Katzenellenbogen J.A. Halo enol lactone inhibitors of chymotrypsin Burst kinetics and enantioselectivity of inactivation . Biochem Biophys Res Commun. 178:1991;1335-1342.
34. Stone S.R., Morrison J.F. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues. Biochim Biophys Acta. 869:1986;275-285.
35. Takamura H., Narita H., Park H.J., Tanaka K., Matsuura T., Kito M. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem. 262:1987;2262-2269.
36. Inoue H., Mori T., Shibata S., Koshihara Y. Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema. Br J Pharmacol. 96:1989;204-210.
37. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.